I presented the newest data on treatment of metastatic pancreatic cancer, in other words, cancer that has spread to other organs. It has made progress in the chemotherapeutic treatment of this doctrine.

Pancreatic cancer is a cancer that is very hard to treat, many times having a very negative prognosis. Progress in pancreatic cancer is of uncertain nature. This last year we’ve had two new treatments for metastatic pancreatic cancer arise.

Have any medical trials been carried out?

A so called gemcitabine, with nab-paclitaxel, which is a combination utilised, superior to gemcitabine on its own, when dealing with metastatic pancreatic cancer. Another is a combination called folfirinox, which is a mix of four medications, the first is called oxaliplatin, the second is irinotecan, the other is 5-FU, and the last is leucovorin, which optimizes the effectiveness of the 5-FU. 
I believe that Latin America is in progress as well. Latin America is doing research in ----- and medications for cancer tumours in general. More research is needed still, in pancreatic tumours, not only in Latin America, but in the entire world. The amount of research done for the study of pancreatic cancer is very small, except for in the United States. The progress in treatments for pancreatic cancer is still quite uncertain; research is still being carried out. Currently we are researching in the discovery of new vaccines that are improving in quality, and we have high hopes that it will improve the treatment of pancreatic cancer. Vaccines for tumours, as well as vaccines for other types of antigens or proteins, that is capable of activating the immune system, to fight against cancerous pancreatic cells. There are studies being carried out, as well, with chemotherapeutic agents that are not only capable of acting against pancreatic cancer, but, very importantly, the area that is adjacent to the pancreatic tumour, referred to as the stroma. This area is very difficult to penetrate with chemotherapy. We currently promote agents that act in this area; they improve the penetration of chemotherapy in these pancreatic cells.